|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61P 27/02 | (2006.01) | ||
| A61K 31/55 | (2006.01) |
| (11) | Number of the document | 1968594 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06838635.8 |
| Date of filing the European patent application | 2006-11-29 | |
| (97) | Date of publication of the European application | 2008-09-17 |
| (45) | Date of publication and mention of the grant of the patent | 2010-09-29 |
| (46) | Date of publication of the claims translation | 2010-11-25 |
| (86) | Number | PCT/US2006/045776 |
| Date | 2006-11-29 |
| (87) | Number | WO 2007/064752 |
| Date | 2007-06-07 |
| (30) | Number | Date | Country code |
| 740478 P | 2005-11-29 | US |
| (72) |
BRIGANDI, Richard Anthony, US
LEVICK, Mark, US
MILLER, William Henry, US
|
| (73) |
GlaxoSmithKline LLC,
One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Neovaskulinių susirgimų, tokių kaip makulos degeneracija, angioidų ruoželiai, uveitas ir makulos edema, gydymas |
| TREATMENT OF OCULAR NEOVASCULAR DISORDERS SUCH AS MACULAR DEGENERATION, ANGIOD STREAKS, UVEITIS AND MACULAR EDEMA |
| Payment date | Validity (years) | Amount | |
| 2013-10-28 | 8 | 640.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-11-29 |